DE60024243D1 - Verbesserte krebsbehandlung mit temozolomid - Google Patents

Verbesserte krebsbehandlung mit temozolomid

Info

Publication number
DE60024243D1
DE60024243D1 DE60024243T DE60024243T DE60024243D1 DE 60024243 D1 DE60024243 D1 DE 60024243D1 DE 60024243 T DE60024243 T DE 60024243T DE 60024243 T DE60024243 T DE 60024243T DE 60024243 D1 DE60024243 D1 DE 60024243D1
Authority
DE
Germany
Prior art keywords
temozolomide
cancer treatment
improved cancer
improved
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60024243T
Other languages
English (en)
Other versions
DE60024243T2 (de
Inventor
H Ragab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE60024243D1 publication Critical patent/DE60024243D1/de
Application granted granted Critical
Publication of DE60024243T2 publication Critical patent/DE60024243T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60024243T 1999-03-30 2000-03-27 Verbesserte krebsbehandlung mit temozolomid Expired - Lifetime DE60024243T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28134899A 1999-03-30 1999-03-30
US281348 1999-03-30
PCT/US2000/008079 WO2000057867A2 (en) 1999-03-30 2000-03-27 Improved cancer treatment with temozolomide

Publications (2)

Publication Number Publication Date
DE60024243D1 true DE60024243D1 (de) 2005-12-29
DE60024243T2 DE60024243T2 (de) 2006-08-17

Family

ID=23076905

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60024243T Expired - Lifetime DE60024243T2 (de) 1999-03-30 2000-03-27 Verbesserte krebsbehandlung mit temozolomid

Country Status (18)

Country Link
EP (1) EP1165071B1 (de)
JP (2) JP2002540148A (de)
CN (2) CN102160864A (de)
AR (1) AR023185A1 (de)
AT (1) ATE310515T1 (de)
AU (1) AU780892B2 (de)
BR (1) BR0009380A (de)
CA (1) CA2368614C (de)
DE (1) DE60024243T2 (de)
DK (1) DK1165071T3 (de)
ES (1) ES2251987T3 (de)
HK (1) HK1044111B (de)
HU (1) HUP0200805A3 (de)
NO (1) NO330651B1 (de)
NZ (1) NZ536302A (de)
TW (1) TWI276434B (de)
WO (1) WO2000057867A2 (de)
ZA (1) ZA200107736B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100366249C (zh) 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
CN1742723A (zh) * 2004-09-02 2006-03-08 天津倍方科技发展有限公司 含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途
CN1299772C (zh) * 2004-10-14 2007-02-14 孔庆忠 一种抗癌药物组合物
US20060100188A1 (en) * 2004-11-09 2006-05-11 Chen Zong Treatment methods
RS53082B (en) * 2006-01-17 2014-06-30 Abbvie Bahamas Ltd. COMBINED THERAPY WITH PARP INHIBITORS
CN103751186B (zh) * 2006-04-05 2016-08-24 欧科生医股份有限公司 药物制剂：8-[{1-(3,5-双-(三氟甲基)苯基)-乙氧基}-甲基]-8-苯基-1,7-二氮杂-螺[4.5]癸-2-酮的盐及用其治疗的方法
AR061618A1 (es) * 2006-06-26 2008-09-10 Schering Corp Formas de dosificacion unitaria de temozolomida
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
ZA200901970B (en) * 2006-09-29 2010-01-27 Cipla Ltd An improved process for the preparation of temozolomide and analogs
WO2012075210A2 (en) * 2010-12-01 2012-06-07 Niiki Pharma Inc. Method for treating refractory cancer
CN102526038B (zh) * 2011-01-12 2013-09-11 北京人福军威医药技术开发有限公司 替莫唑胺的脑靶向药物组合物及其应用
CN107397735B (zh) * 2017-07-28 2020-07-10 东曜药业有限公司 一种替莫唑胺药物组合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859630B1 (de) * 1995-10-04 2002-12-11 Schering Corporation Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
CA2184546A1 (en) * 1996-07-31 1998-02-01 Margaret H. Dugan Method for treating pediatric high grade astrocytoma including brain stem glioma
CA2184545A1 (en) * 1996-07-31 1998-02-01 Pascale Reidenberg Cancer treatment with temozolomide

Also Published As

Publication number Publication date
BR0009380A (pt) 2001-12-26
ATE310515T1 (de) 2005-12-15
WO2000057867A3 (en) 2001-04-19
WO2000057867A2 (en) 2000-10-05
NZ536302A (en) 2006-05-26
EP1165071A2 (de) 2002-01-02
AU780892B2 (en) 2005-04-21
JP2007169297A (ja) 2007-07-05
CN1345240A (zh) 2002-04-17
CN102160864A (zh) 2011-08-24
ES2251987T3 (es) 2006-05-16
NO20014725L (no) 2001-11-13
AR023185A1 (es) 2002-09-04
DK1165071T3 (da) 2006-02-20
EP1165071B1 (de) 2005-11-23
DE60024243T2 (de) 2006-08-17
CA2368614A1 (en) 2000-10-05
HUP0200805A3 (en) 2004-07-28
CA2368614C (en) 2008-07-22
TWI276434B (en) 2007-03-21
NO330651B1 (no) 2011-05-30
ZA200107736B (en) 2003-02-26
HK1044111A1 (en) 2002-10-11
HK1044111B (zh) 2006-02-24
JP2002540148A (ja) 2002-11-26
AU3924400A (en) 2000-10-16
NO20014725D0 (no) 2001-09-28
HUP0200805A2 (hu) 2002-07-29

Similar Documents

Publication Publication Date Title
DK1637127T3 (da) Terapeutisk mikroskum
NO20021400L (no) Terapeutiske kinazolinderivater
DE60001530T2 (de) Verbinder
DE60006630D1 (de) Verbinder
DE60020922D1 (de) Verbinder
FI20000863A (fi) Uusi hoitomenetelmä
AR028476A1 (es) Tratamiento del cancer
DE60008069D1 (de) Verbinder
DE60019059D1 (de) Verbinder
DE60001032D1 (de) Verbinder
DE60017816D1 (de) Herzschrittmacher
DE60023454D1 (de) Lagenmaterialen mit tensid-modifizierten chelatbildern behandelt
NO20020358L (no) Anvendelse av etodolac til behandling av kreft
DE60015473D1 (de) Verbinder
ATE310515T1 (de) Verbesserte krebsbehandlung mit temozolomid
DE60001783D1 (de) Verbinder
DE60016600D1 (de) Herzschrittmacher
DE59911113D1 (de) Herzschrittmacher
DE60003993D1 (de) Verbinder
NO20013596D0 (no) Slambehandling
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
ATE302165T1 (de) Wasserbehandlung
DE60013608D1 (de) Herzschrittmacher
DE60012162D1 (de) Verbinder
DE60017062D1 (de) Verbinder

Legal Events

Date Code Title Description
8364 No opposition during term of opposition